Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
28K characters. Original on sec.gov · Markdown
Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) (1) List of financial statements filed as part of this Form 10-K
The consolidated financial statements of Martin Marietta and consolidated subsidiaries, and related notes, appear in Item 8, “Financial Statements and Supplemental Data,” of this Form 10-K.
(2) List of financial statement schedules filed as part of this Form 10-K
The following financial statement schedule of Martin Marietta and consolidated subsidiaries is included in Item 15(c) of this Form 10-K.
Schedule II - Valuation and Qualifying Accounts
All other schedules have been omitted because they are not applicable, not required, or the information has been otherwise supplied in the financial statements or notes to the financial statements.
The report of the Company’s independent registered public accounting firm with respect to the above-referenced financial statements is included in Item 8, “Financial Statements and Supplemental Data,” of this Form 10-K. The report on the financial statement schedule and the consent of the Company’s independent registered public accounting firm are attached as Exhibit 23.01 to this Form 10-K.
(3) Exhibits
The list of Exhibits on the accompanying Index of Exhibits included in Item 15(b) of this Form 10-K is hereby incorporated by reference. Each management contract or compensatory plan or arrangement required to be filed as an exhibit is indicated by asterisks.
(b) Index of Exhibits
| Celebrating 25 Years as a Public Company | ![]() | Form 10-K ♦ Page 121 |
|---|
Part IV ♦ Item 15 – Exhibits and Financial Statement Schedules
| Form 10-K ♦ 122 | ![]() | Celebrating 25 Years as a Public Company |
|---|
Part IV ♦ Item 15 – Exhibits and Financial Statement Schedules
| Celebrating 25 Years as a Public Company | ![]() | Form 10-K ♦ Page 123 |
|---|
Part IV ♦ Item 15 – Exhibits and Financial Statement Schedules
| Form 10-K ♦ 124 | ![]() | Celebrating 25 Years as a Public Company |
|---|
Part IV ♦ Item 15 – Exhibits and Financial Statement Schedules
| Exhibit No. | |
|---|---|
| *32.02 | --Certification dated February 21, 2020 of Chief Financial Officer required by 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| *95 | --Mine Safety Disclosure Exhibit |
| *101 | --The following financial information formatted in Inline XBRL: |
| *101.INS | --XBRL Instance Document |
| *101.SCH | --XBRL Taxonomy Extension Schema Document |
| *101.CAL | --XBRL Taxonomy Extension Calculation Linkbase Document |
| *101.LAB | --XBRL Taxonomy Extension Label Linkbase Document |
| *101.PRE | --XBRL Taxonomy Extension Presentation Linkbase Document |
| *101. DEF | --XBRL Taxonomy Extension Definition Linkbase |
| *104 | --The cover page financial information formatted in Inline XBRL (included as Exhibit 101). |
Other material incorporated by reference:
Martin Marietta Materials, Inc.’s 2020 Proxy Statement to be filed pursuant to Regulation 14A, portions of which are incorporated by reference in this Form 10-K. Those portions of the 2020 Proxy Statement which are not incorporated by reference shall not be deemed to be “filed” as part of this report.
| * | Filed herewith |
|---|
| ** | Management contract or compensatory plan or arrangement required to be filed as an exhibit pursuant to Item 14(c) of Form 10-K |
|---|
| Celebrating 25 Years as a Public Company | ![]() | Form 10-K ♦ Page 125 |
|---|
Part IV ♦ Item 15 – Exhibits and Financial Statement Schedules
(c) Financial Statement Schedule
SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS
MARTIN MARIETTA MATERIALS, INC. AND CONSOLIDATED SUBSIDIARIES
| Col A | Col B | Col C | Col D | Col E | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additions | ||||||||||||||||||||||
| Description | Balance at beginning of period | (1) Charged to costs and expenses | (2) Charged to other accounts- describe | Deductions- describe | Balance at end of period | |||||||||||||||||
| (Amounts in Millions) | ||||||||||||||||||||||
| Year ended December 31, 2019 | ||||||||||||||||||||||
| Allowance for doubtful accounts | $ | 3.3 | $ | 1.4 | $ | — | $ | — | $ | 4.7 | ||||||||||||
| Allowance for uncollectible notes receivable | — | — | — | — | — | |||||||||||||||||
| Inventory valuation allowance | 159.2 | 38.8 | — | 29.4 | (a) | 168.6 | ||||||||||||||||
| Year ended December 31, 2018 | ||||||||||||||||||||||
| Allowance for doubtful accounts | $ | 2.4 | $ | 0.9 | $ | — | $ | — | $ | 3.3 | ||||||||||||
| Allowance for uncollectible notes receivable | 0.2 | — | — | 0.2 | (b) | — | ||||||||||||||||
| Inventory valuation allowance | 144.0 | 36.9 | 5.1 | (c) | 26.8 | (a) | 159.2 | |||||||||||||||
| Year ended December 31, 2017 | ||||||||||||||||||||||
| Allowance for doubtful accounts | $ | 6.3 | $ | — | $ | — | $ | 3.9 | (b) | $ | 2.4 | |||||||||||
| Allowance for uncollectible notes receivable | 0.4 | — | — | 0.2 | (b) | 0.2 | ||||||||||||||||
| Inventory valuation allowance | 134.9 | 38.5 | — | 29.4 | (a) | 144.0 |
| (a) | Sale of reserved inventory and divestitures |
|---|
| (b) | Write-off of uncollectible accounts and change in estimates |
|---|
| (c) | Application of reserve policy to acquired inventories |
|---|
Previous: Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES · Next: Item 16. FORM 10-K SUMMARY
